As more people around the globe race to get COVID-19 vaccines, governments and the health care sector are trying to balance the risks and rewards. We take a closer look at how a “one size fits all” mentality could disrupt the inroads made so far with Jason Kolbert, Director of research at Dawson James, and long-time Wall Street biotech analyst.

DISCLAIMER: This video is presented for informational and entertainment purposes. The views discussed in the interview should not be taken as investment advice. Please consult a financial advisor before making any financial decisions.